|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/42 | (2006.01) |
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 2982372 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15182562.7 |
| Date of filing the European patent application | 2006-04-05 | |
| (97) | Date of publication of the European application | 2016-02-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation | 2020-10-26 |
| (30) | Number | Date | Country code |
| 668735 P | 2005-04-05 | US | |
| 669774 P | 2005-04-07 | US | |
| 690187 P | 2005-06-13 | US | |
| 694621 P | 2005-06-27 | US | |
| 756472 P | 2006-01-04 | US |
| (72) |
CORIC, Vladmir, US
KRYSTAL, John H., US
SANACORA, Gerard, US
|
| (73) |
Yale University,
Office of Cooperative Research, 433 Temple Street, New Haven, CT 06511,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Glutamatą moduliuojantys agentai psichikos sutrikimų gydymui |
| GLUTAMATE MODULATING AGENTS IN THE TREATMENT OF MENTAL DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2025-03-18 | 20 | 347.00 EUR |